Insidermedicine Daily News (Video)
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured ...
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured by Google News and The News Room. April 25, 2007 Patients with HIV who are treated with protease inhibitors have an increased risk of heart attack, according to a study published in the New England Journal of Medicine. Combination antiretroviral therapy has had a dramatic effect in reducing illness and death associated with the HIV virus, however an earlier study showed that the risk of heart attacks increased by 17% with every year a patient spent on antiretroviral. It isn’t known, though, whether all antiretroviral drugs carry this risk. The assessment of the role of any specific drug is difficult because patients with HIV usually receive a combination of drugs, and often switch regimens because of the availability of newer substances, adverse events, or drug regimen failure. Previous studies have shown a relationship between the use of protease inhibitors, a class of antiretroviral drug, and cardiovascular disease, but there is little information on the risks associated with another class of antiretroviral therapy called nonnucleoside reverse-transcriptase inhibitors. In this study, more than 23,000 patients infected with the HIV virus were assessed to determine the incidence of heart attack and the association between heart attack and exposure to protease inhibitors or nonnucleoside reverse-transcriptase inhibitors. Confirming the earlier results, the researchers found the risk of having a heart attack increased by 16% per year of exposure to protease inhibitors alone, which is equal to twice the risk over five years. Not such effect was observed with nonnucleoside reverse-transcriptase inhibitors. It is thought that protease inhibitors raise the level of blood lipid, thereby increasing the risk of cardiovascular disease and heart attack. Patients treated with protease inhibitors should have their cholesterol and blood pressure levels monitored, and take steps to reduce their lifestyle-related risk factors. This includes maintaining a healthy weight, eating a low-fat diet rich in fruits in vegetables, and getting regular exercise. Reporting for Insidermedicine, I'm Dr. Susan Sharma.
Show all Visit Show Website http://www.insidermedicine.caRecently Aired
-
HD
Light Physical Activity May Improve Heart Health
(Aug 14, 2012 - Insidermedicine) From London - According to ...
(Aug 14, 2012 - Insidermedicine) From London - According to a new report regular leisure-time physical activity may help improve heart health. Appearing in the journal Circulation, study participants who reported being mildly physically active in their leisure time; including activities such as brisk walking, home maintenance, and gardening, had lower blood levels of inflammatory markers.
-
HD
Triclosan Found To Impair Muscle Function In Animals
(Aug 14, 2012 - Insidermedicine) From California - Triclosan, a ...
(Aug 14, 2012 - Insidermedicine) From California - Triclosan, a widely used antibacterial agent, has been found to impair muscle function in animal models. The compound is found in a number of products such as hand soap, toothpaste and deodorant. Appearing online in the Proceedings of the National Academy of Sciences, researchers found both reduced heart muscle function and grip strength in exposed mice.
-
HD
Mild Activity Improves Heart Health; Concerns About Triclosan; Drug Delivery With Hydrogel
(Aug 14, 2012 - Insidermedicine) From London - According to ...
(Aug 14, 2012 - Insidermedicine) From London - According to a new report regular leisure-time physical activity may help improve heart health. Appearing in the journal Circulation, study participants who reported being mildly physically active in their leisure time; including activities such as brisk walking, home maintenance, and gardening, had lower blood levels of inflammatory markers. From California - Triclosan, a widely used antibacterial agent, has been found to impair muscle function in animal models. The compound is found in a number of products such as hand soap, toothpaste and deodorant. Appearing online in the Proceedings of the National Academy of Sciences, researchers found both reduced heart muscle function and grip strength in exposed mice. From Cambridge - A new hydrogel has been developed that could allow one injection to deliver therapeutic proteins and other compounds for up to 6 months. Published in Biomaterials, the hydrogel is more than 99% water, and can have its payload incorporated at room temperature, which is significant as many proteins lose their properties when exposed to high temperatures.
-
HD
Two Dose Hepatitis A Vaccine Lasts At Least A Decade
(Aug 3, 2012 - Insidermedicine) From Atlanta - Researchers followed ...
(Aug 3, 2012 - Insidermedicine) From Atlanta - Researchers followed nearly 200 infants and toddlers in the US receiving a two dose inactivated hepatitis A vaccine. They found that ten years after receiving their second dose of vaccine, most of the children still had antibodies for hepatitis A. Appearing in the journal Hepatology the researchers also found that the mother's hepatitis A antibody status did not significantly influence the child's response to the vaccine.
-
HD
Diabetes Risk of Statins Outweighed by Benefits
(Aug 13, 2012 - Insidermedicine) From Boston - A new ...
(Aug 13, 2012 - Insidermedicine) From Boston - A new report published online in The Lancet finds that the increased risk of developing diabetes when taking statins is outweighed by the cardiovascular benefits. Analyzing data from the JUPITER study, study participants on statins who had at least one risk factor for diabetes were 28% more likely to develop it. These patients however, were also 39% less likely to develop cardiovascular disease while on statins, and were 17% less likely to die during the the study period.
-
HD
Progress Toward Alzheimer's Blood Test
(Aug 13, 2012 - Insidermedicine) From Atlanta - For years ...
(Aug 13, 2012 - Insidermedicine) From Atlanta - For years researchers have been trying to create a blood test for detecting Alzheimer's disease and new research online ahead of print in Neurology may bring us one step closer. Researchers examined the blood levels of 190 proteins in people with Alzheimer's, mild cognitive impairment, and healthy controls. 17 of the proteins were associates with MCI/AD. When they cross referenced their results with the Alzheimer's Disease Neuroimaging Initiative, 4 of the proteins remained as potential biomarkers.
-
HD
Alzheimer's Biomarkers; Statins And Diabetes Risk; Hepatitis A Vaccine Lasts 10 Years or More
(Aug 13, 2012 - Insidermedicine) From Atlanta - For years ...
(Aug 13, 2012 - Insidermedicine) From Atlanta - For years researchers have been trying to create a blood test for detecting Alzheimer's disease and new research online ahead of print in Neurology may bring us one step closer. Researchers examined the blood levels of 190 proteins in people with Alzheimer's, mild cognitive impairment, and healthy controls. 17 of the proteins were associates with MCI/AD. When they cross referenced their results with the Alzheimer's Disease Neuroimaging Initiative, 4 of the proteins remained as potential biomarkers. From Boston - A new report published online in The Lancet finds that the increased risk of developing diabetes when taking statins is outweighed by the cardiovascular benefits. Analyzing data from the JUPITER study, study participants on statins who had at least one risk factor for diabetes were 28% more likely to develop it. These patients however, were also 39% less likely to develop cardiovascular disease while on statins, and were 17% less likely to die during the the study period. From Atlanta - Researchers followed nearly 200 infants and toddlers in the US receiving a two dose inactivated hepatitis A vaccine. They found that ten years after receiving their second dose of vaccine, most of the children still had antibodies for hepatitis A. Appearing in the journal Hepatology the researchers also found that the mother's hepatitis A antibody status did not significantly influence the child's response to the vaccine.
-
HD
Vaccine has potential to reverse type 1 diabetes; New test improves PSA screening; Corticosteroids not effective at treating sinusitis
(August 12, 2012 - Insidermedicine Week in Review) From Massachusetts ...
(August 12, 2012 - Insidermedicine Week in Review) From Massachusetts - A generic vaccine may have the potential to reverse diabetes, according to a report published in PLoS ONE. Researchers randomized six type 1 diabetes patients to receive either the BCG vaccine (approved for use against tuberculosis and bladder cancer) or placebo. Results showed BCG treatment killed autoimmune cells that prevent insulin-secretion and temporarily restored insulin production. From New York - A novel test has the ability of diagnose aggressive prostate cancer, according to a report published in the Journal of Urology. Researchers studied nearly 300 men with high prostate-specific antigen levels but a history of negative biopsies, giving the men a two-drug combination designed to reduce their PSA levels. Men whose PSA levels had minimal change were biopsied again, and researchers successfully identified high-grade tumours without administering unnecessary biopsies. From the Netherlands - Corticosteroids are not effective at treating acute sinusitis, according to a report published in the Canadian Medical Association Journal. Randomizing nearly 200 adults with acute sinusitis to either daily prednisone or placebo for a week, researchers found no difference in clinical benefits between the two groups.
-
HD
Cholesterol declining among US youth; New way to deliver Herceptin speeds breast cancer treatment; Dementia strongly associated with delirium
(August 11, 2012 - Insidermedicine Week in Review) From Atlanta ...
(August 11, 2012 - Insidermedicine Week in Review) From Atlanta - Cholesterol levels among American youth are improving, according to a report published in the Journal of the American Medical Association. Researchers reviewed data on over 16,000 children aged 6-19 years old, finding that average total cholesterol levels have decreased since 1988, though nearly 1 in 10 American youth still have high cholesterol From Brazil - Research published in the Lancet Oncology describes a novel method of delivering a common breast cancer drug that can dramatically speed up breast cancer treatment. Results of a Phase III clinical trial found that subcutaneous delivery of Herceptin was just as effective as intravenous delivery, greatly accelerating delivery of the drug and offering the potential for at-home administration by the patient. From Cambridge - Delirium dramatically increases risk of dementia in the elderly, according to a report published in Brain. Studying nearly 600 individuals over the age of 85, researchers found that those who experienced episodes of delirium were 8x more likely to develop dementia.
-
HD
Prednisone does little in treating acute sinusitis
(August 10, 2012 - Insidermedicine) From the Netherlands - Corticosteroids ...
(August 10, 2012 - Insidermedicine) From the Netherlands - Corticosteroids are not effective at treating acute sinusitis, according to a report published in the Canadian Medical Association Journal. Randomizing nearly 200 adults with acute sinusitis to either daily prednisone or placebo for a week, researchers found no difference in clinical benefits between the two groups.
